Search Results - Nigel S Key

Refine Results
  1. 1

    Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis by Victor R. Gordeuk, Nigel S. Key, Josef T. Prchal

    Published in Haematologica (2019-04-01)
    Get full text
    Article


  2. 2

    Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria by Ming Y. Lim, Keith E. Volmar, Nigel S. Key

    Published in Case Reports in Hematology (2019-01-01)
    Get full text
    Article


  3. 3

    Adverse clinical outcomes associated with sickle cell trait at high altitude by Katherine A. Stafford, Soravis Osataphan, Rushad Patell, Nigel S. Key

    Published in Haematologica (2024-10-01)
    Get full text
    Article


  4. 4

    Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer by Raj S. Kasthuri, Yohei Hisada, Anton Ilich, Nigel S. Key, Nigel Mackman

    Get full text
    Article


  5. 5

    Using heparin molecules to manage COVID‐2019 by Jian Liu, Jine Li, Katelyn Arnold, Rafal Pawlinski, Nigel S. Key

    Get full text
    Article


  6. 6

    An exploratory study of the effects of strenuous exercise on markers of coagulation activation, circulating microparticles, and inflammation in sickle cell trait by Sarah Skinner, Eric D. Ryan, Harry C. Stafford, Robert G. McMurray, Nigel S. Key, Micah J. Mooberry

    Published in eJHaem (2020-07-01)
    Get full text
    Article


  7. 7

    Hemodialysis-Related Complement and Contact Pathway Activation and Cardiovascular Risk: A Narrative Review by Sarah C. Skinner, Vimal K. Derebail, Caroline J. Poulton, Donna C. Bunch, Prabir Roy-Chaudhury, Nigel S. Key

    Published in Kidney Medicine (2021-07-01)
    Get full text
    Article


  8. 8

    Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause by Callie Berkowitz, Alice Ma, Vanessa Miller, Supreet Goraya, Kristi Kirkland, Julie Grabell, Nigel S. Key, Paula D. James

    Get full text
    Article


  9. 9

    Angiopoietin2 is associated with coagulation activation and tissue factor expression in extracellular vesicles in COVID-19 by Mayck Silva Barbosa, Franciele de Lima, Carla Roberta Peachazepi Moraes, Ivanio Teixeira Borba-Junior, Stephany Cares Huber, Irene Santos, Bruna Bombassaro, Sergio San Juan Dertkigil, Anton Ilich, Anton Ilich, Nigel S. Key, Nigel S. Key, Nigel S. Key, Joyce M. Annichino-Bizzacchi, Joyce M. Annichino-Bizzacchi, Fernanda Andrade Orsi, Eli Mansour, Licio A. Velloso, Licio A. Velloso, Erich Vinicius De Paula, Erich Vinicius De Paula

    Published in Frontiers in Medicine (2024-05-01)
    Get full text
    Article


  10. 10

    Excess of heme induces tissue factor-dependent activation of coagulation in mice by Erica M. Sparkenbaugh, Pichika Chantrathammachart, Shaobin Wang, Will Jonas, Daniel Kirchhofer, David Gailani, Andras Gruber, Raj Kasthuri, Nigel S. Key, Nigel Mackman, Rafal Pawlinski

    Published in Haematologica (2015-03-01)
    Get full text
    Article


  11. 11

    Development and application of global assays of hyper‐ and hypofibrinolysis by Anton Ilich, Denis F. Noubouossie, Michael Henderson, Patrick Ellsworth, Kathleen F. Molitor, Elena Campello, Shannon Meeks, Amy Dunn, Myung S. Park, Rafal Pawlinski, Paolo Simioni, Amy Shapiro, Nigel S. Key

    Get full text
    Article


  12. 12

    Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B by Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe

    Published in Blood Advances (2019-11-01)
    Get full text
    Article


  13. 13

    Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients by Milena Elimelakh, Vanessa Dayton, Katharine S. Park, Angelika C. Gruessner, David Sutherland, Robert B. Howe, Mark T. Reding, Ted Eastlund, Jo-Anne van Burik, Timothy P. Singleton, Rainer W. Gruessner, Nigel S. Key

    Published in Haematologica (2007-08-01)
    Get full text
    Article


  14. 14

    Erratum to “Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome” [Kidney International Reports Volume 9, Issue 10, October 2024, Pages 3053-3056] by David Massicotte-Azarniouch, Daniel J. Crona, Priscilla Karnabi, Bhadran Bose, Patrick H. Nachman, Marc Carrier, Mark Canney, David W. Johnson, Taewoo Lee, Raja Ramachandran, Vivekanand Jha, Nigel S. Key, Vimal K. Derebail

    Published in Kidney International Reports (2025-04-01)
    Get full text
    Article


  15. 15

    Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study by Robert Klamroth, Michael Recht, Nigel S. Key, Wolfgang Miesbach, Steven W. Pipe, Radoslaw Kaczmarek, Douglass Drelich, Blanca Salazar, Sandra Le Quellec, Paul E. Monahan, Nicholas Galante, Paul van der Valk, Jacqueline Tarrant

    Get full text
    Article


  16. 16

    Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model by Fatima Trebak, Mohammad O. Sako, Steven P. Grover, Karnsasin Seanoon, Izabela Pawlinski, Chatphatai Moonla, Michael W. Henderson, Vimal K. Derebail, Dougald M. Monroe, Patrick Ellsworth, Rafal Pawlinski, Malgorzata Kasztan, Nigel S. Key

    Published in Blood Advances (2025-06-01)
    Get full text
    Article


  17. 17

    Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome by David Massicotte Azarniouch, Daniel J. Crona, Priscilla Karnabi, Bhadran Bose, Patrick H. Nachman, Marc Carrier, Mark Canney, David W. Johnson, Taewoo Lee, Raja Ramachandran, Vivekanand Jha, Nigel S. Key, Vimal K. Derebail

    Published in Kidney International Reports (2024-10-01)
    Get full text
    Article


  18. 18

    Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years by Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan U. Lattimore, Frank W. G. Leebeek, Wolfgang A. Miesbach, Michael Recht, Paul E. Monahan, Sandra Le Quellec, Steven W. Pipe

    Published in Blood Advances (2025-07-01)
    Get full text
    Article


  19. 19

    Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors by Yohei Hisada, Steven P. Grover, Anaum Maqsood, Reaves Houston, Cihan Ay, Denis F. Noubouossie, Brian C. Cooley, Håkan Wallén, Nigel S. Key, Charlotte Thålin, Ádám Z. Farkas, Veronika J. Farkas, Kiril Tenekedjiev, Krasimir Kolev, Nigel Mackman

    Published in Haematologica (2020-01-01)
    Get full text
    Article


  20. 20

    Endothelial alterations in a canine model of immune thrombocytopenia by Dana N. LeVine, Rachel E. Cianciolo, Keith E. Linder, Petra Bizikova, Adam J. Birkenheuer, Marjory B. Brooks, Abdelghaffar K. Salous, Shila K. Nordone, Dwight A. Bellinger, Henry Marr, Sam L. Jones, Thomas H. Fischer, Yu Deng, Marshall Mazepa, Nigel S. Key

    Published in Platelets (2019-01-01)
    Get full text
    Article


Search Tools: